Panelist Bios

Alfred W. Campbell

Pathologist, Carolinas Pathology Group
President, Celligent Diagnostics LLC

Alfred W. Campbell, MD, MBA is a member of Carolinas Pathology Group and Chief of Pathology at Spartanburg Regional Medical Center in Spartanburg, South Carolina, where he is a practicing general surgical and cytopathologist and director of Transfusion Medicine, Histology and Point of Care Testing. Dr. Campbell is President of Celligent Diagnostics, LLC, an independent anatomic and cytology laboratory, and a member of the board of Carolinas Pathology Group. His undergraduate degree is from The Texas A&M University, medical degree is from the University of Texas at Houston McGovern School, pathology residency is from the University of Texas Southwestern in Dallas, and MBA is from the University of South Carolina Darla Moore School of Business.

Dr. Campbell has held numerous positions in organized medicine and pathology, including past president for the American Pathology Foundation, Virginia Society of Pathology, South Carolina Society of Pathologists, and the Roanoke Academy of Medicine. He has also served as 2nd vice president of the Medical Society of Virginia and Treasurer of PathPAC, and he is currently a board member of the College of American Pathologists.

Richard Cooper, Esq

Co-Chair of National Healthcare Practice Group, McDonald Hopkins, LLC

Mr. Cooper is the co-chair of McDonald Hopkins’ National Healthcare Practice Group as well as its Healthcare Restructuring Practice Group, and he served on the firm’s Board of Directors from 1992-2012. He focuses his national practice in healthcare law, representing clients in transactional, restructuring, corporate, compliance, regulatory, licensure, reimbursement, contractual, strategic planning, and venture matters.

Practice group clients include private practice and academic physician groups, hospitals and health systems (including tax-exempt, physician and investor owned hospitals, critical access to large systems and academic medical centers), physician networks, laboratories (anatomic, clinical, molecular, toxicology, and specialty), healthcare associations and

societies, hospitalists and hospitalist companies, multi-specialty clinics, medical staffs, imaging centers, surgery centers, outpatient medical facilities, home health providers, drug and alcohol treatment facilities, occupational medicine companies, healthcare technology companies, and healthcare billing and management companies. Mr. Cooper earned a J.D., cum laude, from Georgetown University Law Center in 1981 and received a B.A., cum laude, from Syracuse University in 1978.

Raj C. Dash, MD

Professor and Vice-Chair, Pathology IT, Duke University Health System

Dr. Dash is a board-certified pathologist with fellowship training in Cytopathology and Informatics. He currently serves as the Beaker physician champion and Director for Laboratory Informatics Strategy, reporting to the office of the Chief Health Information Officer for Duke Health. He has an undergraduate degree in computer science and specializes in medical informatics, fine needle aspiration cytology and surgical pathology of breast cancer. Dr. Dash is involved in the research and development of medical terminologies and associated software tools for medical data mining and analysis. He is the principal author of Duke’s primary biorepository informatics platform managing samples and associated clinical data, called MAW3®, which has been in development since 1998, has served in a production environment since 2000.

Dr. Dash is active on a number of national and international committees, including serving as a Co-Chair of the Integrating the Healthcare Enterprise (IHE) Pathology and Laboratory Medicine (PaLM) Domain, and serving the College of American Pathologists on their Informatics Committee, Web Engagement Steering Committee, CAP Foundation Board, and the Board of Governors.

Kathleen Fondren, MBA, MT (ASCP)

CEO, CellNetix Pathology and Laboratories

Kathleen Fondren is an experienced healthcare executive with broad knowledge and expertise in hospital, laboratory and medical group practice operations and leadership. Before joining CellNetix in 2014, she was the Assistant Administrator/Clinical Executive at Highline Medical Center, part of CHI Franciscan Health. As a member of the hospital senior executive team, Ms. Fondren had oversight for multiple clinical departments. She was instrumental in improving quality and reducing the overall cost of patient care. Some of her key accomplishments were the design, build and opening of an outpatient imaging center, a 32-bed state-of-the-art emergency department and securing Joint Commission Primary Stroke Center Accreditation.

Ms. Fondren is passionate about excellence in patient care and improving patient outcomes by delivering high quality, cutting edge technology to physicians and patients. She received a bachelor’s degree in Medical Technology from the University of Wyoming and later went on to receive a Master’s in Business Administration from University of Wyoming in 2010.

Mick Raich

Owner, Vachette Pathology

Mick Raich founded Vachette in 2002 to help generate and ensure revenue from independent laboratories, hospital laboratories, healthcare systems, community hospitals, and pathology practices by auditing and restructuring RCM processes from an outside point of view. His 39 years in healthcare has helped him build an intimate understanding of

the revenue-cycle process, managed care negotiations, Part A negotiations, group merger and hospital negotiations, and revenue strategy in the laboratory business. Mr. Raich is a nationally recognized speaker on changes in the laboratory revenue-cycle industry and has presented for numerous state societies, universities and industry publications. Vachette has worked with hundreds of clients across the continental United States.

Cory Roberts, M.D., M.B.A

President, CEO, and Chairman of the Board, ProPath

Dr. Roberts is a board-certified clinical and anatomic pathologist at ProPath, sub-specializing in gastrointestinal and hepatic pathology. ProPath is the largest, completely physician-owned pathology practice with a nationwide sales team in the US. At ProPath, he has been the President and Chairman of the Board since 2011, led the company through a successful re-organization in 2016, and was named as its first Chief Executive Officer in 2017. Dr. Roberts also serves on the Scientific Advisory Board at Reveal Biosciences, the Gastroenterology Expert Panel at Allakos, the Thought Leadership Initiative at Leica, the Board of Directors of Morningside University, and as a laboratory industry consultant for Glenview Capital Management. Prior to joining ProPath, he was an Assistant Professor of Pathology and Director of the Residency Program at the University of Nebraska Medical Center.

Dr. Roberts has written four books, numerous peer-reviewed publications, book chapters, and abstracts. He has lectured widely in his sub-specialty and on topics related to the business of pathology. He obtained his B.S. in Biology from Morningside University, his M.D. from the University of Nebraska Medical Center, and his M.B.A. from University of North Texas at Dallas.

Stephen Ruby, MD, MBA

CEO, RubyGroup, Ltd.
Founding Partner, WhiteCoat Risk Management, Inc.

Dr. Stephen G. Ruby is a board certified Anatomic and Clinical Pathologist. His 35+ year pathology career includes the founding of 4path, Ltd., an AP laboratory which services the Great Lakes region. He has over 45 years’ experience in laboratory medicine, holding positions as Medical Director, Chairman of a community hospital and medical entrepreneur. Dr. Ruby completed a fellowship in Surgical Pathology with emphasis in dermatopathology and has an MBA in innovation and technology. He is past president of the Illinois and Chicago Pathology Societies and past chair of the Practice Management Committee of the CAP. He also served on the committee that developed the Manual for the Reporting of Cancer Specimens.

Dr. Ruby has numerous peer-reviewed publications and serves as a section editor of the Archives of Pathology and Laboratory Medicine, as well as reviewer for other pathology journals. He published the first in a series of books My Doctor Says I have…. which help patients better understand their disease processes. Dr. Ruby co-founded WhiteCoat Risk Management, providing consultation and insurance resources for physicians, including ensuring cost-effective risk protection for personal, professional and practice business needs.

Karim Sirgi, MD, MBA

CEO, Sirgi Consulting, LLC
Founding Partner, Medicolegal Consultants International, LLP

Dr. Karim Sirgi is a pathologist, certified in Anatomic, Clinical and Cytopathology with additional subspecialty fellowship training in surgical pathology. He also holds an MBA and has over 30 years of practice and leadership experience in private, academic and hospital-based pathology and laboratory practices, as well as state and national professional pathology and laboratory organizations. Among leadership positions held, Dr. Sirgi is a past president of the Colorado Society of Clinical Pathologists; the College of American Pathologists Foundation; Unipath PC, a multispecialty pathology group in Denver, CO; the medical staff of Presbyterian-Saint Luke’s Hospital, a tertiary care facility in Denver; and the Presidents’ Council of Health One, part of the Health One Healthcare System in Colorado.

Dr. Sirgi currently owns and manages healthcare consulting companies, including Sirgi Consulting, LLC, offering expertise to medical groups in organizational leadership, physicians group dynamics and communication, succession planning, governance structure, physician wellness, physician engagement, strategic planning, and group retreat facilitation. He volunteers as medical director of The Colorado Center for Medical Laboratory Science, a medical technology school, and serves on the boards of multi-million-dollar companies, start-up ventures, and community-based and national philanthropic and non-profit foundations

Robert H. Tessier, MPH

Senior Reimbursement Consultant, HBP Services

After completing his bachelor’s degree in Political Science at Providence College, Robert H. Tessier received a Master’s in Public Health (MPH) in 1972, with a concentration in Health Planning, from the University of North Carolina in Chapel Hill. Shortly after joining Professional Management Services in Massachusetts, Mr. Tessier became Executive Vice President and Director of Consulting. He focused on hospital and third-party negotiations, as well as the development of complex practice plans. As Reimbursement Consultant to several state societies, Mr. Tessier consistently secured favorable financial arrangements. From 1972 to 1982, most of his clients were radiology groups, including large academic medical centers.

In 1982, Mr. Tessier established HBP Services. They were retained by Cornell/New York Hospital to set up the first private practice in New York City. A subsequent engagement at Yale Pathology included third-party negotiations on behalf of the Connecticut State Pathology Society. In 2019, he became a founding organizer of the Panel of National Pathology Leaders, a think tank dedicated to advancing best practices in pathology.

Josh Yelen, MBA/HA MAccy

VP of Revenue Cycle Strategy & Divisional GM, Strategic Initiatives, FrontRunnerHC

Josh Yelen’s work in healthcare administration has focused on physician practice management, hospital administration, clinical laboratory medicine and anatomic pathology. While serving as the Vice Chair for Administration in the University of Miami’s Department of Pathology, Mr. Yelen consolidated 20 esoteric independent labs and 3 hospital labs into one core lab infrastructure, saving millions of dollars in lab operating expenses. Under his leadership, Pathology at UMiami grew fourfold in revenue and from a deficit to a largely margin positive producing program.

Mr. Yelen also has experience in managed care contracting, ACOs, PCMHs, Managed Medicaid/Medicare and Bundled payments, and how to capitalize on environmental changes. He holds an MBA with a focus in Healthcare Administration (MBA/HA) from the University of Miami and a bachelor’s degree from Indiana University. The local Miami newspaper, the Miami Herald, awarded Mr. Yelen their “20 Under 40 Award” as a prominent business and civic leader under 40 years of age in Miami.



Robert De La Torre, MBA

COO, Pathology Specialists of Arizona

Bob De La Torre served as the Chief Operating Officer for Pathology Specialists of Arizona, a 65- member limited liability partnership, for 25 years. The group provides pathology services in the hospital, ambulatory surgery and outreach markets of Arizona. One of its major contracts includes a strategic partnership with Sonora Quest Laboratories, the largest commercial laboratory in Arizona. Operations within the corporation in addition to pathology services include a standalone billing company and a histology/molecular pathology laboratory.

Mr. De La Torre has been a consultant member of the CAP’s Practice Management Committee. He is also an active speaker at CAP educational conferences, the American Society of Clinical Pathologists and the American Pathology Foundation. His prior experiences have included various
management positions in hospital administration and the laboratory. He received his undergraduate degree from the University of Washington and his MBA from Arizona State University.

Jane Pine Wood, Esq

Chief Legal Counsel, BioReference Laboratories

Jane Pine Wood is a nationally respected healthcare attorney who has been practicing law for over 32 years. She specializes in laboratory regulatory and compliance matters and has counseled more than 500 pathology groups and 350 clinical laboratories. She was appointed Chief Legal and Compliance Officer of BioReference Laboratories in 2016, prior

to which she spent 29 years with the multi-state law firm McDonald Hopkins LLC. Ms. Wood is a frequent speaker at national and state laboratory and pathology meetings, is a contributor to association publications and is regularly quoted in the national press. Ms. Wood graduated from the Vanderbilt University School of Law.

Krista Tinsley, CPA


With over 25 years’ experience in managing and growing anatomic pathology laboratories and practices, Krista Tinsley is one of the leading consultants in the industry. She was Executive Director of ProPath (one of the largest physician-owned pathology practices and laboratories) for over 20 years, leading ProPath through comprehensive transformation and growth. Ms. Tinsley recently rejoined the board of the American Pathology Foundation (APF) for a third term. She was a board member of the North Texas Accountable Healthcare Partnership, which sponsored the area’s regional Health Information Exchange, and served on the executive committee of the Pathology Management Assembly of MGMA.

Prior to joining ProPath, Ms. Tinsley was Chief Financial Officer for Ameritrust, a trust and investment management organization which administered over $67 billion in assets. She holds a degree in accounting and marketing from Dallas Baptist University, is a licensed Texas Certified Public Accountant, a Chartered Global Management Accountant (CGMA) and a Certified Medical Practice Executive.

Scroll to Top